Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000344535 | SCV000428340 | likely benign | Hepatic veno-occlusive disease-immunodeficiency syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Labcorp Genetics |
RCV000344535 | SCV000763944 | benign | Hepatic veno-occlusive disease-immunodeficiency syndrome | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001281000 | SCV001468396 | uncertain significance | Hepatic veno-occlusive disease-immunodeficiency syndrome; Mycobacterium tuberculosis, susceptibility to | 2021-03-30 | criteria provided, single submitter | clinical testing | SP110 NM_004509.3 exon 5 c.584-10C>G: This variant has not been reported in the literature but is present in 0.3% (446/128970) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-231077155-G-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:334913). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Genome Diagnostics Laboratory, |
RCV001706546 | SCV001929801 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001706546 | SCV001970595 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003969964 | SCV004783974 | likely benign | SP110-related disorder | 2023-10-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |